Sono-Tek Corporation reported fiscal second-quarter and first-half 2027 results for periods ended August 31, 2026. First-half net sales were $10,893,312, up 6% year over year; gross margin was 55%, versus 51%. Operating income rose 41% to $1,278,692, and net income increased 22% to $1,107,462. Medical-market sales climbed 289% to $7,050,000, led by balloon-coating and specialty stent-coating systems.
Second-quarter net sales increased 1% to $5,232,153, while operating income declined 9% to $381,531 and net income declined 14% to $366,294. Alternative Energy sales decreased 85% to $855,000 in the first half; Sono-Tek attributed the decline to shifts in U.S. government policy and spending in that sector. Management reiterated its expectation of flat to modest revenue growth for fiscal 2027, citing the timing of several large, higher-value production platform orders, which can increase quarter-to-quarter variability as these systems become a larger portion of the business. It said recent new record orders significantly increase revenue visibility for fiscal 2028. Cash and cash equivalents were $10,249,779 as of August 31, 2026.
Joseph Riemer, a director of Sono-Tek Corp (SOTK), exercised vested options on October 12, 2026, in six reported tranches: 2,000 at $2.65, 6,050 at $3.19, 3,300 at $5.50, 3,676 at $4.79, 4,267 at $4.12, and 3,158 at $3.25 per share. He also surrendered 10,631 SOTK common shares as payment for the option exercises. No Rule 10b5-1 plan is reported.
Sono Tek Corp CFO Stephen James Bagley exercised 7,722 vested options on October 12, 2026, at an exercise price of $4.12 per share. The transaction also records disposition to the issuer of 7,722 SonoTek options. Bagley surrendered 4,494 SonoTek common shares as payment for the exercise of options; his reported option position following the transaction was 32,695.
Sono-Tek Corp. (SOTK) COO Christopher Cichetti reported exercising 9,978 vested options on October 8, 2026, acquiring 9,978 common shares at a $3.25 exercise price. He surrendered 4,804 common shares as payment for the exercise and reported disposition of 9,878 Sono-Tek options to the issuer. The reported derivative position following the disposition was 82,753 options.
Sono-Tek Corp. Vice President Brian Lewis Booth exercised 3,293 vested options at $3.25 per share and 2,027 vested options at $4.12 per share on October 6, 2026. He surrendered 1,572 and 1,226 shares of Sono-Tek common stock, respectively, as payment for those exercises. The records also list the related options as disposed to the issuer. No Rule 10b5-1 plan is reported.
Sono-Tek Corp director Christopher L. Coccio exercised 13,158 vested options on October 5, 2026, at an exercise price of $3.25 per share. The report also records disposition to the issuer of 13,158 options. Coccio surrendered 6,897 common shares as payment for the option exercise. His reported derivative position following the disposition was 104,572 options.
Sono Tek Corp (SOTK) CFO Stephen James Bagley exercised 5,488 vested options on October 5, 2026, at an exercise price of $3.25 per share. He surrendered 2,877 common shares, reported at $6.20 per share, to pay the exercise price. His reported option holdings after the transaction were 40,417. The option record lists an expiration date of August 21, 2035.
R. Stephen Harshbarger, Sono-Tek Corp.’s CEO, reported exercising 13,171 vested options on October 6, 2026, at an exercise price of $3.25 per share. The same-date derivative transaction reports disposition to the issuer of 13,171 options, with 87,304 options reported following that disposition. Harshbarger also surrendered 6,286 common shares as payment for the option exercise.
SONO TEK CORP (SOTK) reported a compensation-related option grant to officer Maria T. Kuha, who serves as VP. On 2026-08-20 she received 7,205 Sono-Tek options with an exercise price of $5.35 per share, exercisable into an equal number of Sono-Tek Corp common shares. These options become exercisable on 2027-08-20 and expire on 2036-08-20. Following this grant, her reported directly held derivative position in these options is 35,001 options.
SONO TEK CORP (SOTK) reported that officer Christopher Cichetti, Vice President, received a grant of 12,968 Sono-Tek options on 2026-08-20. These options have a conversion or exercise price of $5.35 per share, become exercisable on 2027-08-20, and expire on 2036-08-20. Following this grant, Cichetti directly holds 92,731 options in total.